Wenlin Cheng

1.4k total citations
33 papers, 891 citations indexed

About

Wenlin Cheng is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Wenlin Cheng has authored 33 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Cell Biology. Recurrent topics in Wenlin Cheng's work include MicroRNA in disease regulation (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Wenlin Cheng is often cited by papers focused on MicroRNA in disease regulation (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Wenlin Cheng collaborates with scholars based in China, Saudi Arabia and Sri Lanka. Wenlin Cheng's co-authors include Jianlei Cao, Xiaorong Hu, Qiang Liu, Yakun Liu, Wen‐Jun Tu, Lei Yu, Hongliang Li, Zhi‐Gang She, Fu‐Han Gong and Xue‐Yong Zhu and has published in prestigious journals such as Circulation, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Wenlin Cheng

28 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenlin Cheng China 14 323 281 214 162 153 33 891
Rami M. Elshazli Egypt 18 407 1.3× 273 1.0× 178 0.8× 190 1.2× 119 0.8× 65 1.1k
Bihong Zhao United States 17 271 0.8× 316 1.1× 152 0.7× 248 1.5× 218 1.4× 61 1.2k
Jing Tao China 13 242 0.7× 262 0.9× 114 0.5× 186 1.1× 69 0.5× 28 729
Monia Maccaferri Italy 10 457 1.4× 193 0.7× 247 1.2× 158 1.0× 50 0.3× 16 869
Liang Shao China 14 218 0.7× 208 0.7× 141 0.7× 116 0.7× 85 0.6× 32 645
Tobias Weinberger Germany 9 563 1.7× 199 0.7× 345 1.6× 101 0.6× 198 1.3× 18 1.0k
Hongquan Guan China 11 334 1.0× 280 1.0× 210 1.0× 99 0.6× 33 0.2× 15 794
Sara Socorro Faria Brazil 10 132 0.4× 241 0.9× 57 0.3× 226 1.4× 109 0.7× 20 731
Jeffrey D. Neidhart United States 6 621 1.9× 150 0.5× 428 2.0× 179 1.1× 116 0.8× 11 987
Weichen Lin China 8 355 1.1× 154 0.5× 186 0.9× 89 0.5× 98 0.6× 13 694

Countries citing papers authored by Wenlin Cheng

Since Specialization
Citations

This map shows the geographic impact of Wenlin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlin Cheng more than expected).

Fields of papers citing papers by Wenlin Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlin Cheng. The network helps show where Wenlin Cheng may publish in the future.

Co-authorship network of co-authors of Wenlin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlin Cheng. A scholar is included among the top collaborators of Wenlin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlin Cheng. Wenlin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Xu, Dong, et al.. (2024). ETS1 Expression in Diabetic Foot Ulcers: Implications for Fibroblast Phenotype and Wound Healing Through the PP2A/YAP Pathway. Journal of Inflammation Research. Volume 17. 7373–7388.
5.
Liu, Xintian, Haojie Zhang, Wenlin Cheng, et al.. (2023). Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study. Frontiers in Pharmacology. 14. 1291896–1291896.
6.
Cheng, Wenlin, et al.. (2023). Inhibition of P21-activated Kinase 1 Promotes Vascular Smooth Muscle Cells Apoptosis Through Reduction of Phosphorylation of Bad. American Journal of Hypertension. 37(1). 46–52. 2 indexed citations
7.
Cheng, Wenlin, Huanhuan Cai, Ke‐Qiong Deng, et al.. (2023). N-Acetylcysteine Alleviates Phenylephrine-Induced Cardiomyocyte Dysfunction via Engaging PI3K/AKT Signaling Pathway. American Journal of Hypertension. 37(3). 230–238. 3 indexed citations
8.
He, Yi, Xin Yi, Zihao Zhang, et al.. (2022). JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells. Clinical Epigenetics. 14(1). 101–101. 15 indexed citations
9.
Cheng, Wenlin, Quan Zhang, Bo Li, et al.. (2021). PAK1 Silencing Attenuated Proinflammatory Macrophage Activation and Foam Cell Formation by Increasing PPARγ Expression. Oxidative Medicine and Cellular Longevity. 2021(1). 6957900–6957900. 15 indexed citations
10.
Wang, Yaqi, Kai Wang, Wenlin Cheng, & Yunquan Zhang. (2021). Global burden of chronic obstructive pulmonary disease attributable to ambient ozone in 204 countries and territories during 1990–2019. Environmental Science and Pollution Research. 29(6). 9293–9305. 10 indexed citations
11.
Wang, Man, Yongzhen Fan, Wenlin Cheng, et al.. (2021). Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China. Frontiers in Cellular and Infection Microbiology. 11. 667487–667487. 11 indexed citations
12.
Xu, Jing, et al.. (2020). [The clinical significance of plasma PTX3 in patients with secondary hemophagocytic lymphohistiocytosis].. PubMed. 59(7). 528–534. 1 indexed citations
13.
Cao, Jianlei, Wen‐Jun Tu, Wenlin Cheng, et al.. (2020). Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clinical Infectious Diseases. 71(15). 748–755. 373 indexed citations
14.
Gong, Fu‐Han, Wenlin Cheng, Haiping Wang, et al.. (2018). Reduced atherosclerosis lesion size, inflammatory response in miR-150 knockout mice via macrophage effects. Journal of Lipid Research. 59(4). 658–669. 24 indexed citations
15.
Li, Tao, Juan‐Juan Qin, Yang Xia, et al.. (2017). The Ubiquitin E3 Ligase TRAF6 Exacerbates Ischemic Stroke by Ubiquitinating and Activating Rac1. Journal of Neuroscience. 37(50). 12123–12140. 61 indexed citations
16.
Zhang, Xin, Jing Li, Juan‐Juan Qin, et al.. (2017). Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages. Journal of Lipid Research. 58(5). 895–906. 55 indexed citations
17.
Deng, Ke‐Qiong, Jing Li, Zhi‐Gang She, et al.. (2017). Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway. Hypertension. 70(4). 770–779. 37 indexed citations
18.
Liu, Hui, Wenlin Cheng, Xi Jiang, et al.. (2017). Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice. Hypertension. 69(3). 510–520. 33 indexed citations
19.
Guan, Hongjing, Wenlin Cheng, Junhong Guo, et al.. (2017). Vinexin β Ablation Inhibits Atherosclerosis in Apolipoprotein E–Deficient Mice by Inactivating the Akt–Nuclear Factor κB Inflammatory Axis. Journal of the American Heart Association. 6(2). 12 indexed citations
20.
Kuo, Han‐Yueh, Chih‐Man Yang, Ming-Feng Lin, et al.. (2009). Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan. Diagnostic Microbiology and Infectious Disease. 66(2). 195–199. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rami M. Elshazli Breakdown of academic impact, for papers by Bihong Zhao Breakdown of academic impact, for papers by Jing Tao Breakdown of academic impact, for papers by Monia Maccaferri Breakdown of academic impact, for papers by Liang Shao Breakdown of academic impact, for papers by Tobias Weinberger Breakdown of academic impact, for papers by Hongquan Guan Breakdown of academic impact, for papers by Sara Socorro Faria Breakdown of academic impact, for papers by Jeffrey D. Neidhart Breakdown of academic impact, for papers by Weichen Lin
Rankless by CCL
2026